Latest Financial Stability News

Range International Limited reported a robust Q2 2025 with revenue surging 75% year-over-year and strong operational momentum despite supply challenges. The company’s strategic moves in Indonesia and the Philippines, alongside a favorable tax court ruling, set the stage for an ambitious growth trajectory.

Openn Negotiation Ltd has reported a remarkable financial turnaround in its half-year results to December 2024, shifting from a significant loss to a modest profit while divesting key subsidiaries.

Openn Negotiation Limited reported a $245k net cash outflow from operations in Q1 2025, offset partially by $211k in financing activities, leaving the company with just $6k in cash. The company depends on interest-free loans from its major shareholder to sustain operations amid limited liquidity.

Energy Action Ltd reports a robust Q4 FY25 with significant revenue growth, sustained positive cash flow, and strategic refinancing, while advancing its AI-driven Utilibox platform and zero-carbon solutions.

Beonic Limited reported a landmark $15.2 million contract win in North Africa alongside strong Q4 FY25 EBITDA profitability and positive cash flow, signaling robust operational momentum heading into FY26.

BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.

Donaco International’s Q4 FY2025 results reveal a revenue dip driven by geopolitical tensions at its Star Vegas casino, while its Vietnam hotel posts gains. Meanwhile, the company’s proposed acquisition by On Nut Road Limited moves closer to shareholder approval.

Synlait Milk Limited reports a significant financial turnaround for FY25 with expected underlying EBITDA doubling from the prior year, while overcoming manufacturing setbacks at its Dunsandel facility.

Icon Energy Limited reported a stable cash position of $431,414 at the end of June 2025, with no exploration activity during the quarter as it awaits final approval of Petroleum Lease PL-1144. The company plans to pursue joint venture partnerships once the lease is granted.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 45 active trials worldwide and anticipates UK revenue by Q2 FY26 following successful supermarket partnerships.

Radiopharm Theranostics reports significant progress in its oncology radiopharmaceutical pipeline, including FDA Fast Track designation and dose escalation approvals, supported by a solid cash runway through mid-2026.

Aroa Biosurgery has reported its third consecutive quarter of positive net cash flow, maintaining a strong cash position and reaffirming its FY26 revenue and EBITDA guidance. The company’s Myriad product sales continue to grow, supported by new clinical evidence.